ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20260054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Florence Assan und 48 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetic of Skin Diseases, Imagine Institute, INSERM UMR1163, Paris, France. Hauptthemen laut MEDLINE: Adenosine Deaminase, Psoriasis, RNA Editing, RNA-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Programme Hospitalier de Recherche Clinique, Agence Nationale de la Recherche, French Society for Dermatology.
Abstract (Originalsprache)
Recent evidence implicates altered RNA editing and dysregulated type I IFN signaling in immune-mediated diseases, including psoriasis, although the underlying genetic mechanisms remain poorly defined. We investigated four unrelated multiplex families with early-onset plaque psoriasis, with or without psoriatic arthritis, segregating as a monogenic trait and characterized by a strong IFN signature in skin and blood. Whole-exome sequencing identified four rare heterozygous loss-of-function mutations in ADAR1 cosegregating with disease and elevated IFN-stimulated gene expression. Six additional rare variants were detected in an independent cohort of 125 psoriasis patients. Single-cell transcriptomics identified keratinocytes and melanocytes as major IFN sources. Functional studies showed that ADAR1 knockdown or expression of ADAR1G1119R and ADAR1P3A alleles pathogenic variants reduced adenosine-to-inosine RNA editing and increased IFN-stimulated genes and inflammatory cytokines, effects reversed by upadacitinib and deucravacitinib. These findings define a novel IFN-dependent psoriasis subtype caused by inborn defects of ADAR1-mediated RNA editing, with direct implications for precision medicine in psoriatic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Genetic of Skin Diseases, Imagine Institute, INSERM UMR1163, Paris, France.
- Université Paris Cité , Paris, France.
- Bioinformatics Platform, Imagine Institute, INSERM UMR1163, Paris, France.
- Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
- Proteomics Platform Necker - Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR3633 , Paris, France.
- Genomics Platform, Imagine Institute, INSERM UMR1163, Paris, France.
ORCID-Profile: Florence Assan, Margot Tragin, Sahiti Marella, Joanna Lipecka, Kévin Roger, Mohammed Zarhrate, Vincent Bondet, Vincent Nguyen, Fadela Akroun, Patrick Nitschké, Ida Chiara Guerrera, Christine Bole, Araksya Izmiryan, Maria Emilia Puig-Lombardi, Jennifer Fox, Joseph Kirma, Haihan Zhang, Yiqian Gu, Rachael Bogle, Katia Boniface, Julien Seneschal, Luis Seabra, Alice Lepelley, Marie-Louise Frémond, Nadège Bondurand, Emmauelle Jouanguy, Robert L Modlin, Jean-Laurent Casanova, Jeremy Di Domizio, Michel Gilliet, Emilie Sbidian, Maxime Battistella, Emmanuel Mahé, Sarah Guégan, Lam C Tsoi, Pascal Richette, Pascal Claudepierre, Arnaud Rigolet, Claire Giannesini, Antonio Costanzo, Darragh Duffy, Brad R Rosenberg, Dharshini Sathishkumar, Emmanuelle Bourrat, Chung Hsing Chang, Alain Hovnanian, Johann E Gudjonsson, Yanick J Crow, Hervé Bachelez
Förderung
- Programme Hospitalier de Recherche Clinique
- Agence Nationale de la Recherche
- French Society for Dermatology
- Institut National de la Santé et de la Recherche Médicale
- Paris Cité University
- Pfizer
- French Foundation for Medical Research
Zitieren
APA
Assan, F., Tragin, M., Marella, S., Lipecka, J., Roger, K., Zarhrate, M., Bondet, V., Nguyen, V., Akroun, F., Nitschké, P., Guerrera, I. C., Bole, C., Izmiryan, A., Puig-Lombardi, M. E., Fox, J., Kirma, J., Zhang, H., Gu, Y., Bogle, R., …, & Bachelez, H. (2026). ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20260054
Vancouver
Assan F, Tragin M, Marella S, Lipecka J, Roger K, Zarhrate M, et al. ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20260054
BibTeX
@article{Assan2026,
author = {Assan, Florence and Tragin, Margot and Marella, Sahiti and Lipecka, Joanna and Roger, Kévin and Zarhrate, Mohammed and Bondet, Vincent and Nguyen, Vincent and Akroun, Fadela and Nitschké, Patrick and Guerrera, Ida Chiara and Bole, Christine and Izmiryan, Araksya and Puig-Lombardi, Maria Emilia and Fox, Jennifer and Kirma, Joseph and Zhang, Haihan and Gu, Yiqian and Bogle, Rachael and Boniface, Katia and Seneschal, Julien and Seabra, Luis and Lepelley, Alice and Frémond, Marie-Louise and Bondurand, Nadège and Jouanguy, Emmauelle and Modlin, Robert L and Casanova, Jean-Laurent and Di Domizio, Jeremy and Gilliet, Michel and Sbidian, Emilie and Battistella, Maxime and Mahé, Emmanuel and Guégan, Sarah and Tsoi, Lam C and Richette, Pascal and Claudepierre, Pascal and Rigolet, Arnaud and Giannesini, Claire and Costanzo, Antonio and Duffy, Darragh and Rosenberg, Brad R and Sathishkumar, Dharshini and Bourrat, Emmanuelle and Chang, Chung Hsing and Hovnanian, Alain and Gudjonsson, Johann E and Crow, Yanick J and Bachelez, Hervé},
title = {ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20260054}
}
EUVIMED